Evaluation of direct inoculation of the BD PHOENIX system from positive BACTEC blood cultures for both Gram-positive cocci and Gram-negative rods

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Beuving, Judith ^a   Van Der Donk, Christina Fm ^a   Linssen, Catharina Fm ^a   Wolffs, Petra Fg ^a   Verbon, Annelies ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COLISTIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULFAMETHOXAZOLE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BLOOD CULTURE; BLOODSTREAM INFECTION; BROTH DILUTION; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROCOCCUS; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; INOCULATION; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS; BACTEREMIA; BLOOD; DIAGNOSTIC ERROR; DRUG EFFECT; EVALUATION; GRAM NEGATIVE FACULTATIVELY ANAEROBIC RODS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SENSITIVITY AND SPECIFICITY; STATISTICS;

ENTEROBACTERIACEAE; ENTEROCOCCUS; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; DIAGNOSTIC ERRORS; GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS; GRAM-POSITIVE COCCI; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 79959631026     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-156     Document Type: Article

References (27)

1. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. DC Angus WT Linde-Zwirble J Lidicker G Clermont J Carcillo MR Pinsky, Critical care medicine 2001 29 7 1303 1310 10.1097/00003246-200107000-00002 11445675 (Pubitemid 32641789)
2. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. VY Dombrovskiy AA Martin J Sunderram HL Paz, Critical care medicine 2005 33 11 2555 2562 10.1097/01.CCM.0000186748. 64438.7B 16276180 (Pubitemid 41682108)
3. The epidemiology of sepsis in the United States from 1979 through 2000. GS Martin DM Mannino S Eaton M Moss, The New England journal of medicine 2003 348 16 1546 1554 10.1056/NEJMoa022139 12700374 (Pubitemid 36437931)
4. Sepsis in European intensive care units: results of the SOAP study. JL Vincent Y Sakr CL Sprung VM Ranieri K Reinhart H Gerlach R Moreno J Carlet JR Le Gall D Payen, Critical care medicine 2006 34 2 344 353 10.1097/01.CCM. 0000194725.48928.3A 16424713 (Pubitemid 43145611)
5. Bacteremias: a leading cause of death. GM Bearman RP Wenzel, Archives of medical research 2005 36 6 646 659 10.1016/j.arcmed.2005.02.005 16216646 (Pubitemid 41436234)
6. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Barenfanger C Drake G Kacich, Journal of clinical microbiology 1999 37 5 1415 1418 10203497 (Pubitemid 29187810)
7. Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands. M Bruins H Oord P Bloembergen M Wolfhagen A Casparie J Degener G Ruijs, Eur J Clin Microbiol Infect Dis 2005 24 5 305 313 10.1007/s10096-005-1309-7 15834750 (Pubitemid 40897514)
8. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. JJ Kerremans P Verboom T Stijnen L Hakkaart-van Roijen W Goessens HA Verbrugh MC Vos, The Journal of antimicrobial chemotherapy 2008 61 2 428 435 18156278
9. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. GV Doern R Vautour M Gaudet B Levy, Journal of clinical microbiology 1994 32 7 1757 1762 7929770 (Pubitemid 24189570)
10. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. A Fraser M Paul N Almanasreh E Tacconelli U Frank R Cauda S Borok M Cohen S Andreassen AD Nielsen,, et al. The American journal of medicine 2006 119 11 970 976 10.1016/j.amjmed.2006.03.034 17071166 (Pubitemid 44634308)
11. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. EH Ibrahim G Sherman S Ward VJ Fraser MH Kollef, Chest 2000 118 1 146 155 10.1378/chest.118.1.146 10893372 (Pubitemid 30485502)
12. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. A Kumar D Roberts KE Wood B Light JE Parrillo S Sharma R Suppes D Feinstein S Zanotti L Taiberg,, et al. Critical care medicine 2006 34 6 1589 1596 10.1097/01.CCM. 0000217961.75225.E9 16625125 (Pubitemid 43810035)
13. Accuracy of identification and susceptibility results by direct inoculation of Vitek 2 cards from positive BACTEC cultures. JJ Kerremans WH Goessens HA Verbrugh MC Vos, Eur J Clin Microbiol Infect Dis 2004 23 12 892 898 15599650 (Pubitemid 40104744)
14. Direct susceptibility testing of positive blood cultures by using Sensititre broth microdilution plates. KC Chapin MC Musgnug, Journal of clinical microbiology 2003 41 10 4751 4754 10.1128/JCM.41.10.4751-4754.2003 14532215 (Pubitemid 37259789)
15. Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panels. KB Waites ES Brookings SA Moser BL Zimmer, Journal of clinical microbiology 1998 36 7 2052 2056 9650961 (Pubitemid 28277801)
16. Use of positive blood cultures for direct identification and susceptibility testing with the vitek 2 system. M de Cueto E Ceballos L Martinez-Martinez EJ Perea A Pascual, Journal of clinical microbiology 2004 42 8 3734 3738 10.1128/JCM.42.8.3734-3738.2004 15297523 (Pubitemid 39045706)
17. Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2. MJ Bruins P Bloembergen GJ Ruijs MJ Wolfhagen, Journal of clinical microbiology 2004 42 1 7 11 10.1128/JCM.42.1.7-11.2004 14715724 (Pubitemid 38082691)
18. Use of the BD PHOENIX Automated Microbiology System for direct identification and susceptibility testing of gram-negative rods from positive blood cultures in a three-phase trial. G Funke P Funke-Kissling, Journal of clinical microbiology 2004 42 4 1466 1470 10.1128/JCM.42.4.1466-1470.2004 15070990 (Pubitemid 38500782)
19. Rapid identification and antimicrobial susceptibility testing of Gram-positive cocci in blood cultures by direct inoculation into the BD Phoenix system. A Lupetti S Barnini B Castagna PH Nibbering M Campa, Clin Microbiol Infect 2010 16 7 986 991 19681952
20. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. CN Baker SA Stocker DH Culver C Thornsberry, Journal of clinical microbiology 1991 29 3 533 538 2037671
21. The E-Test challenged with selected strains. DF Brown, Diagnostic microbiology and infectious disease 1992 15 5 465 468 10.1016/0732-8893(92) 90091-7 1643826
22. Performance Standards for Antimicrobial Susceptiblity Testing; Seventeenth Informational Supplement. CLSI Document M100-17. CLSI, Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania, 19087-1898, USA 2007 27
23. Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures. TK Ling ZK Liu AF Cheng, Journal of clinical microbiology 2003 41 10 4705 4707 10.1128/JCM.41.10.4705-4707.2003 14532207 (Pubitemid 37259781)
24. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. B La Scola D Raoult, PloS one 2009 4 11 8041 10.1371/journal.pone.0008041 19946369
25. Identification and susceptibility testing of Staphylococcus aureus by direct inoculation from positive BACTEC blood culture bottles. BM Diederen M Zieltjens H Wetten AG Buiting, Clin Microbiol Infect 2006 12 1 84 86 10.1111/j.1469-0691.2005.01314.x 16460552 (Pubitemid 43372245)
26. Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of gram-positive cocci and gram-negative bacilli from positive blood cultures. N Wellinghausen T Pietzcker S Poppert S Belak N Fieser M Bartel A Essig, Journal of clinical microbiology 2007 45 3 789 795 10.1128/JCM.01856-06 17202283 (Pubitemid 46427692)
27. Selection criteria for an antimicrobial susceptibility testing system. JH Jorgensen, Journal of clinical microbiology 1993 31 11 2841 2844 8263164 (Pubitemid 23318365)